| (Values in U.S. Thousands) | Dec, 2018 | Dec, 2017 | Dec, 2016 | Dec, 2012 | Sep, 2017 |
| Sales | 3,790 | 3,680 | 3,570 | 10 | 0 |
| Sales Growth | +2.99% | +3.08% | +35,600.00% | unch | unch |
| Net Income | -130 | -370 | -620 | -40 | 0 |
| Net Income Growth | +64.87% | +40.32% | -1,450.04% | unch | unch |
Hypertension Diagnostics Inc (HDII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Hypertension Diagnostics is focused on the development of proprietary cardiovascular profiling technology that analyzes arterial pulse pressure waveform data. HDI has developed two models of it's HDI/PulseWave CardioVascular Profiling Instrument. HDI's first model, the HDI/PulseWave CR-2000, is currently in use by physician scientists for researchpurposes only. The second model, the HDI/PulseWave DO-2020, is intended to assist physicians in screening and diagnosing patients with cardiovascular disease. (PRESS RELEASE)
Fiscal Year End Date: 12/31